Mark Zegal

Mr. Mark Zegal has been appointed to the Company’s Advisory Board to assist with identifying new technologies. Formerly a member of the Chicago Board of Options Exchange, Mr. Zegal has over 20 years of experience in the biotech sector. Mark is a Co-Founder of Brainstorm -Cell Therapeutics, Inc and Brain Pluristem Therapeutics, Inc.